Dapiprazole Hydrochloride

TargetMol
Product Code: TAR-T3996
Supplier: TargetMol
CodeSizePrice
TAR-T3996-1mL1 mL * 10 mM (in DMSO)£95.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3996-10mg10mg£105.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3996-25mg25mg£142.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3996-50mg50mg£181.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3996-100mg100mg£229.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3996-200mg200mg£309.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Dapiprazole Hydrochloride is an alpha-1-adrenergic antagonist that acts by blocking alpha-adrenergic receptors in the smooth muscle of blood vessels (arteries, arterioles and veins), gastrointestinal tract, and radial smooth muscle of the iris.
CAS:
72822-13-0
Formula:
C19H28ClN5
Molecular Weight:
361.92
Pathway:
GPCR/G Protein; Neuroscience
Purity:
0.999
SMILES:
Cl.Cc1ccccc1N1CCN(CCc2nnc3CCCCn23)CC1
Target:
Adrenergic Receptor

References

Silvestrini B., et al. Effects of dapiprazole on pupillary size and intraocular pressure in rabbits. Arzneimittelforschung. 1982;32(6):678-81. Lisciani R., et al. General pharmacological properties of dapiprazole, a potential psychotropic agent. Arzneimittelforschung. 1982;32(6):674-8. Hogan TS., et al. Dose-response study of dapiprazole HCl in the reversal of mydriasis induced by 2.5% phenylephrine. J Ocul Pharmacol Ther. 1997 Aug;13(4):297-302 Silvestrini B., et al. Psychopharmacological profile of dapiprazole, a new potential antipsychotic agent. Arzneimittelforschung. 1982;32(6):668-73. Connor CG., et al. The clinical efficacy of Rev-Eyes in reversing the effects of pupillary dilation. J Am Optom Assoc. 1993 Sep;64(9):634-6.